908 DEVICES INC (MASS)
Information Technology · Handheld analytical instruments / point-of-need chemical analysis · NASDAQ
908 Devices miniaturizes mass spectrometry and optical spectroscopy into handheld devices that deliver real-time chemical analysis at the point of need for frontline workers combating the opioid crisis and detecting security threats.
What 908 DEVICES INC does
908 Devices develops and sells purpose-built handheld devices for point-of-need chemical analysis, leveraging miniaturized mass spectrometry and optical spectroscopy technologies. The company's handheld devices—including MX908, ThreatID, ProtectIR, XplorIR, and VipIR—enable rapid identification of unknown materials in critical applications including detection of fentanyl and illicit drugs, toxic carcinogens, and security threats. Using semiconductor microfabrication techniques to miniaturize mass spectrometry instruments and combining them with complementary vibrational spectroscopy capabilities acquired through RedWave Technology, 908 Devices delivers laboratory-grade analytical answers where and when they are needed in the field.
Themes: Point-of-need chemical analysis, Handheld mass spectrometry, Fentanyl / opioid crisis detection, Toxic carcinogen exposure detection, Global security / threat detection, Counterfeit pharmaceutical detection, Laboratory instrument miniaturization, Optical spectroscopy / vibrational spectroscopy
Fundamentals
- Price$10.68 as of 2026-08-21 close
- Market cap$441M as of 2026-08-21
- 1-year return+77.4% 2025-08-21 close $6.02 → 2026-08-21 close $10.68
- P/E21.44 as of 2026-08-24
- Net margin-62.4% as of 2026-08-24
- Gross margin+51.5% as of 2026-08-24
- ROE-25.6% as of 2026-08-24
- Debt / equity0.00 as of 2026-08-24
- Revenue growth (YoY)-5.9% as of 2026-08-24
- Revenue CAGR (3y)+6.2% SEC XBRL
- Beta0.63 as of 2026-08-24
- Last reported earnings2026-08-11 SEC EDGAR Form 8-K (Item 2.02)
How MASS compares in its sector
- price-to-earnings ratiobottom 25% 265 covered Information Technology peers, as of 2026-08-24
- net profit marginbottom 25% 405 covered Information Technology peers, as of 2026-08-24
- operating marginbottom 25% 405 covered Information Technology peers, as of 2026-08-24
- gross marginmiddle range 403 covered Information Technology peers, as of 2026-08-24
- return on equitybottom 25% 405 covered Information Technology peers, as of 2026-08-24
- 3-year revenue CAGRmiddle range 386 covered Information Technology peers
- free cash flow (absolute dollars, latest fiscal year)bottom 25% 382 covered Information Technology peers, as of FY2025
Position among covered Information Technology companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
How 908 DEVICES INC looks technically
908 DEVICES INC (MASS) is trading 50.8% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 70 trading days ago — a "golden cross", a bullish long-term signal. A strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 41, with buyers in control. Momentum is stretched — its 14-day RSI (a 0–100 momentum gauge) is 78, in overbought territory (above 70). It just made a new 20-day high, pushing above its recent trading range. It is trading right at its highest price of the past year (its 52-week high).
Trend
8
| Distance from the 200-day | it is trading 50.8% above its 200-day average, the long-term trend line — a longer-term uptrend | +50.8% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $8.52 | $8.52 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $7.08 | $7.08 |
| Swing structure | its recent peaks and dips disagree — one of them is rising while the other is not, so there is no clean up or down pattern in the swings | mixed — one of the two is not confirming |
| Last swing turn | its last significant turn was a swing high 9 calendar days ago — the swings before that are what the structure reading is measured on | 9 sessions |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 70 trading days ago — a "golden cross", a bullish long-term signal | 70 sessions |
| Above the 200-day after a dip | it recently dipped to its 200-day average (the long-term trend line) and has since climbed back above it — now about 50.8% above | +50.8% |
| Trend strength (14-day ADX) | a strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 41, with buyers in control | 41.2 |
Momentum
3
| 14-day RSI | momentum is stretched — its 14-day RSI (a 0–100 momentum gauge) is 78, in overbought territory (above 70) | 77.6 |
|---|---|---|
| Position in its 14-day range | it is trading right at the top of its 14-day range ($8.25 to $10.70) — its "stochastic" reading is 99 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 99.1 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, is in positive territory (momentum leaning bullish) | 16 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $10.70 | $10.70 |
|---|---|---|
| From the 52-week high | it is trading right at its highest price of the past year (its 52-week high) | -0.2% |
| Above the 52-week low | it is 112.5% above its 52-week low (its lowest price of the past year) | +112.5% |
| Below the 52-week high | it is at or near its highest point of the past year | 0.2% |
| Since a 20-day breakout | it just made a new 20-day high, pushing above its recent trading range | 1 session |
| Since a 55-day breakout | it just made a new 55-day high, pushing above its recent trading range | 1 session |
| All-time high | its highest closing price on record is $68.11 (set on 2021-02-22) | $68.11 |
| Given back of the 52-week move | over the past year its closes ranged ($5.09 to $10.68), and it has given back essentially none of its rise from last year’s low — 0% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $7.05 to $7.23. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 0.0% |
| From the all-time high | it is 84.3% below its all-time high | -84.3% |
| Nearest price level | it is trading 13.3% above a support level at $9.26 — a price it turned at four times since 2025-10-09, most recently on 2026-06-24. Since 2024-08-21 it has 13 such levels below the current price and 0 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | -13.3% |
| All-time low | its lowest closing price on record is $1.81 (set on 2024-12-24) | $1.81 |
| Above the all-time low | it is 490.1% above its all-time low | +490.1% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are unusually wide versus its own recent history (wider than about 95% of the past ~6 months) | 95th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $0.5696 between its high and its low — about 5.3% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $0.5696 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $6.70 and $11.33 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $6.70 – $9.02 – $11.33 |
| Typical daily range (% of price) | its price moves about 5.3% in a typical session — about typical for the companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 5.3% |
| Stretch from the 200-day average | it is trading 6.3 daily ranges above its 200-day average price (50.8% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 6.3 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 1.30× |
|---|
Analyst
2
| Change in the average price target | analysts have raised their average price target by 18.2% since the prior reading | +18.2% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
3
| Since a doji | 2 sessions ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 2 sessions ago |
|---|---|---|
| Since a bullish engulfing | 1 session ago it opened below the previous session's close and finished above that session's open — a "bullish engulfing" pair, where one up day more than undid the down day before it | 1 session ago |
| Since a bearish engulfing | 5 sessions ago it opened above the previous session's close and finished below that session's open — a "bearish engulfing" pair, where one down day more than undid the up day before it | 5 sessions ago |
Price gaps
3
| Gap at the open | it opened on 2026-08-21 0.6% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | +0.6% |
|---|---|---|
| Open gap | it gapped 4.3% above the previous close 17 sessions ago and has not traded back through the level it left behind at 7.03 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | +4.3% |
| Gap filled | a 2.4% gap down opened on 2026-08-18 has been "filled" 2 sessions ago — price traded back through the level the gap left behind, and it took 1 session to close | 2 sessions ago |
Price streaks
1
| Closing streak | it has closed higher 3 sessions in a row, a +5.95% move over the run — an unbroken run of up days, which describes what has already happened and says nothing about the next session | 3 sessions up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock beat the market by 43.0 percentage points (the stock gained 45.3% while the market gained 2.3%) | +43.0% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock beat the market by 46.9 percentage points (the stock gained 50.0% while the market gained 3.1%) | +46.9% |
| vs market, 6 months | over the past 6 months this stock beat the market by 49.1 percentage points (the stock gained 60.1% while the market gained 11.1%) | +49.0% |
| vs market, 12 months | over the past 12 months this stock beat the market by 56.9 percentage points (the stock gained 77.4% while the market gained 20.5%) | +56.9% |
Signal agreement
2
| Bullish technical signals | 7 of the 9 technical signals we can compute for it are currently in a bullish state: a strong uptrend, with buyers in control, a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average, a fresh 20-day high, MACD momentum is positive, outperforming the market over 6 months, trading above the Ichimoku cloud — these describe past price behaviour, not a forecast | 7 of 9 |
|---|---|---|
| Bearish technical signals | 2 of the 9 technical signals we can compute for it are currently in a bearish state: its RSI momentum gauge is overbought (a stretched reading), near the top of its 14-day range (overbought) — these describe past price behaviour, not a forecast | 2 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 31% above the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-07-16 and projected forward over today's price, the side traders read as an established uptrend, with the band below acting as the level that would have to give way. The band itself is moderate, spanning 2.7% of the share price. | +31.2% |
|---|
Volume-weighted price
1
| Vs this year’s average price paid | the price is 41% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $7.57 — a volume-weighted average of daily closes over 155 sessions, not a true tick-by-tick VWAP. | +41.1% |
|---|
Price levels it has turned at before
MASS last closed at $10.68 on 2026-08-21. Since 2024-08-21 it has turned at 13 prices below its last close and 0 above; the 3 nearest below are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $9.26 | Support | 13.3% below the last close | turned there four times · 2025-10-09 to 2026-06-24 |
| $7.88 | Support | 26.3% below the last close | turned there twice · 2026-03-03 to 2026-06-05 |
| $7.65 | Support | 28.3% below the last close | turned there five times · 2025-06-30 to 2026-07-08 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
No Elliott-wave labelling currently fits its swings: the recent highs and lows do not satisfy the three rules a five-wave count has to obey, so there is no count to show rather than a count we are unsure about.
Read from daily closes as of 2026-08-21.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · Tested and reclaimed 200-day support · Overbought (14-day RSI above 70) · Near the 52-week high · Broke out to a new 20-day high · in a strong, established uptrend (ADX) | Learn: moving average · golden cross · adx · rsi · breakout · fifty two week high low
Based on daily closing prices as of 2026-08-21. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingStrong Buy (1.00 mean, 1=Strong Buy…5=Strong Sell) — 3 analysts
- Mean price target$13.00 range $12.00 – $14.00
Analyst estimates, as of 2026-08-22. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for MASS
- Consensus EPS estimate-$0.14 next reporting period, as of 2026-08-22
Change over time is not available yet: it needs two readings of the same reporting period at least 30 days apart, and we have been recording these estimates since 2026-08-04. An estimate for a DIFFERENT quarter is not a revision, so a reading from before the last report is never compared with one after it.
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Competitive pressure from large established manufacturers of laboratory-based instruments and new market entrants could limit market share and pricing power","Reliance on government and agency customers for significant revenue creates dependence on government funding and budgeting cycles","Heavy operating losses (net margin -62.4%) and declining revenue (-5.89% YoY) suggest execution challenges in scaling the business profitably"]
What changed in the latest 10-Q
AI-assisted comparison of MASS's 10-Q filed 2026-05-06 against the prior one filed 2025-11-10.
Management's Discussion & Analysis (MD&A)
- Added:
- Reference to 2025 Form 10-K filed March 9, 2026 (newer filing dated 2026-05-06)
- Revenue figures for three months ended March 31, 2026 ($13.4 million) and 2025 ($11.8 million)
- Net loss figures for three months ended March 31, 2026 ($12.0 million) and 2025 ($9.8 million)
- Accumulated deficit as of March 31, 2026 ($235.3 million)
- Description of Mass Spec handheld devices (added 'Mass Spec handheld devices' specifically before 'to combat the opioid crisis')
- Reference to 'the ongoing military conflict between Russia and Ukraine and the conflicts in the Middle East'
- Statement that company does not 'directly source any material products or supplies from Russia, Ukraine or the Middle East'
- Removed:
- Reference to 2024 Form 10-K filed March 7, 2025 (older filing dated 2025-11-10)
- Revenue figures for nine months ended September 30, 2025 ($38.8 million) and 2024 ($33.4 million)
- Net loss figures for nine months ended September 30, 2025 ($37.7 million) and 2024 ($37.1 million)
- Accumulated deficit as of September 30, 2025 ($227.5 million)
- Paragraph discussing Federal Reserve interest rate actions and their potential impact on customer ordering patterns
- Text stating 'In addition, while the United States Federal Reserve has recently begun to lower interest rates...'
- Reworded:
- Changed from 'our suppliers and customers' to 'us, and our suppliers and customers' (addition of 'us' before 'and our suppliers')
- Added blank line/formatting change marked by '' character after Global Economic Conditions section
- Notes:
- The older filing text appears truncated at the end, cutting off mid-sentence in the Global Economic Conditions section
- Comparison reflects period-over-period changes (Q1 2026 vs Q3 2025) due to different reporting periods in the two filings
Risk Factors
The two filings could not be meaningfully compared for this section.
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
0 open-market purchases and 19 open-market sales by insiders in the last 90 days.
- Last 30 days0 buys · 2 sells ($587565) — 2 selling insiders
- Last 90 days0 buys · 19 sells ($4M) — 4 selling insiders
- Last 180 days0 buys · 30 sells ($5M) — 6 selling insiders
Activity heuristic: net selling (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-08-05. As of 2026-08-25.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about MASS's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
6 institutional 13F filers reported holding MASS as of 2026-03-31 (quarter-end position, filed within 45 days).
- Distinct 13F filers 6
- Reported shares held 4,725,183
- Reported value $28,918,119
reported quarterly holdings change (2025-12-31 → 2026-03-31): 0 new, 2 increased, 4 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Short interest (FINRA)
MASS had 3,389,065 shares of reported short interest as of the 2026-07-31 FINRA settlement date (delayed, bi-monthly; not real-time).
MASS had 8.20% of its shares outstanding sold short as of the 2026-07-31 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 11.02 days to cover at the same settlement.
- Reported short interest (shares) 3,389,065
- Short interest (% of shares outstanding) 8.20%
- Prior settlement (shares) 3,234,821
- Reported change 4.77%
- Days to cover (reported) 11.02
Reported to FINRA as of the 2026-07-31 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Thermo Fisher Scientific (TMO)
- Agilent Technologies (A)
- Bruker (BRKR)
- PerkinElmer (now Revvity (RVTY))
- Waters Corporation (WAT)
- Sciex (Danaher (DHR))
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare MASS vs…
Frequently asked questions
What does 908 DEVICES INC (MASS) do?
908 Devices develops and sells purpose-built handheld devices for point-of-need chemical analysis, leveraging miniaturized mass spectrometry and optical spectroscopy technologies. The company's handheld devices—including MX908, ThreatID, ProtectIR, XplorIR, and VipIR—enable rapid identification of unknown materials in critical applications including detection of fentanyl and illicit drugs, toxic carcinogens, and security threats.
What sector is 908 DEVICES INC (MASS) in?
908 DEVICES INC (MASS) is classified in the Information Technology sector. Its industry is Handheld analytical instruments / point-of-need chemical analysis. It trades on NASDAQ.
Who are 908 DEVICES INC's (MASS) competitors?
Notable peers of 908 DEVICES INC (MASS) include Thermo Fisher Scientific, Agilent Technologies, Bruker, PerkinElmer (now Revvity (RVTY)) and Waters Corporation. This peer set is informational only — not financial advice.
Is 908 DEVICES INC (MASS) overbought or oversold right now?
908 DEVICES INC (MASS) is currently in overbought territory (its 14-day RSI is 78, above 70) (as of 2026-08-21). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on MASS come from?
Fundamentals and prices come from market data, as of 2026-08-24; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.